![Michael Wheatcroft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Wheatcroft
Direttore Tecnico/Scientifico/R&S presso
TELIX PHARMACEUTICALS LIMITED
Profilo
Michael Wheatcroft currently works at Telix Pharmaceuticals Ltd., as Chief Scientist from 2021.
Dr. Wheatcroft also formerly worked at MedImmune U.K.
Ltd., as Principal and Avipep Pty Ltd., as Research Manager.
Dr. Wheatcroft received his doctorate degree from the University of Cambridge.
Posizioni attive di Michael Wheatcroft
| Società | Posizione | Inizio |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Michael Wheatcroft
| Società | Posizione | Fine |
|---|---|---|
MedImmune U.K. Ltd.
 MedImmune U.K. Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Corporate Officer/Principal | - |
Avipep Pty Ltd.
 Avipep Pty Ltd. Medical SpecialtiesHealth Technology Commercializes protein biopharmaceuticals and in vivo diagnostic products | Corporate Officer/Principal | - |
Formazione di Michael Wheatcroft
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
23
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedImmune U.K. Ltd.
MedImmune U.K. Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Process Industries |
Avipep Pty Ltd.
Avipep Pty Ltd. Medical SpecialtiesHealth Technology Commercializes protein biopharmaceuticals and in vivo diagnostic products | Health Technology |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
